MD PhD. Assistant Professor #Leukemia @MDAndersonNews, Houston (TX). From Barcelona | @hematoclinicbcn. Ski and mountains. I hate all types of cheese.

Houston, TX
Joined February 2015
Alex Bataller retweeted
🎙️Precision medicine is transforming how MDS is managed and treated. In our latest podcast, @AlexBataller, @DrPinkalDesai, Sophie Park, @LabKontro, @thomas_cluzeau, and @Doctor_E_Stein cover the genomic tools, trial data, and emerging therapies shaping this shift. 🎧 Listen here: ow.ly/Tt2Y50ZxnTO #MDSsm #HemOnc #Hematology #TrialUpdate #CTSM #CaGenome
4
5
653
Vibecotamab, an investigational bispecific antibody, has demonstrated activity in low-blast myeloid diseases, with a 67% response rate in patients with #MDS and #CMML after HMA failure. Read more from a study led by @NicholasShortMD and @AlexBataller. ➡️ buff.ly/kyfveuf
1
3
238
Alex Bataller retweeted
Want to hear expert insights on how precision medicine is transforming the management of MDS? 🧬🩸 Tune into our latest podcast featuring @AlexBataller, @DrPinkalDesai, Sophie Park, @LabKontro, @thomas_cluzeau, and @Doctor_E_Stein, as they discuss molecular profiling, targeted therapies, and emerging treatment approaches: 🎧 👉 ow.ly/c8M250ZxnSm #MDSsm #HemOnc #Hematology
2
6
813
Alex Bataller retweeted
Our most recent update of CLAD+LDAC+Ven now published - almost 200 pts with ~3yr f/u ; CR rate 84% and 92% in TP53 wildtype. @alexbataller onlinelibrary.wiley.com/doi/…
1
10
27
2,216
Alex Bataller retweeted
👉👉👉Celebrating last day of heme/Onc fellowship together with our superstar brilliant fellow Dr Hannah Goulart .@HannahGoulart ! Congratulations and wishing her all best as she starts her faculty journey with us here in Leukemia ! @UTMDAnderson @CarinHagberg #leusm #endcancer
2
2
49
2,047
Whole Genome Sequencing [WGS] Reveals Novel, Clinically Relevant Biomarkers Missed by Standards of Care for Pts w/ Myelodysplastic Syndrome [MDS] [Jun 11, 2026] @AlexBataller et al. #EHA2026 EHA-4897 PF656 library.ehaweb.org/eha/2026/… #MDSsm #leusm #cagenome @UTMDAnderson @TempusAI
1
2
243
Whole Genome Sequencing [WGS] Reveals Novel, Clinically Relevant Biomarkers Missed by Standards of Care for Pts w/ Myelodysplastic Syndrome [MDS] [Jun 11, 2026] @AlexBataller et al. #EHA2026 EHA-4897 PF656 library.ehaweb.org/eha/2026/… #MDSsm #leusm #cagenome @UTMDAnderson @TempusAI
1
1
1
4
723
Alex Bataller retweeted
👏👏👏Congratulations to our brilliant Leukemia Chief Fellow Dr .@r_sazevedo on being awarded 🥇 Best Overall Fellow of The Year Award at our Leukemia graduation! Very many Congratulations to each & all of our graduating fellows 👏!!!! @TapKadia @garciamanero 🙌
8
6
63
4,654
Alex Bataller retweeted
👏👏👏Wonderful Leukemia Faculty Dinner 🥘 this evening hosted by Dr @GBorthakur & Dr @garciamanero ! Greatest team to work with ! #leusm #MPNSM #BPDCN #MDSsm #CMMLsm #endcancer 🙌 | @jenweiying
3
3
50
1,662
Alex Bataller retweeted
Whole genome sequencing revealed clinically relevant alterations missed by standard testing in MDS, identifying 21 novel high-confidence variants in 39% of cases, including key structural and prognostic drivers. Presented at #ASCO26 by Dr. Alex Bataller. @AlexBataller @garciamanero #EndCancer 9/12
1
1
8
228
Whole genome sequencing [WGS] to identify novel, clinically relevant findings missed by standard of care for Pts w/ myelodysplastic syndrome [MDS] - @AlexBataller et al @garciamanero @UTMDAnderson @TempusAI #ASCO26 abst 6570 Pst 363 asco.org/abstracts-presentat… #MDSsm #leusm #cagenome
1
2
245
Alex Bataller retweeted
👉👉 👉Congratulations to Dr @AlexBataller & Dr @garciamanero team for wonderful @ASCO poster at #ASCO26 !! @UTMDAnderson #endcancer
1
6
36
1,192
👏Important new paper from our group led by .@TapKadia & @AlexBataller 👉just out in @AjHematology | #Cladribine #leusm #endcancer | @sanamloghavi onlinelibrary.wiley.com/doi/…
16
58
3,743
Whole genome sequencing [WGS] to identify novel, clinically relevant findings missed by standard of care for Pts w/ myelodysplastic syndrome [MDS] - @AlexBataller etal @garciamanero @UTMDAnderson @TempusAI #ASCO26 abst 6570 Pst 363 asco.org/abstracts-presentat… #MDSsm #leusm #cagenome
1
6
555
🔑 KEY FINDING: 52% of patients showed immunophenotypic shifts after revumenib — often myeloid/stem-like → monocytic/myelomonocytic. Among MRD+ patients in remission, 67% had antigen expression changes vs. pre-treatment AML! 👇 @AlexBataller
1
5
474
🧵 NEW PAPER ALERT! Excited to share our work on immunophenotypic changes after menin inhibition in AML, just published in @LeukemiaJnl 🩸 nature.com/articles/s41375-0… #hemepath #leusm #AML #meninInhibitor #revumenib
6
29
5
133
15,613
MD Anderson is proud to be named #1 in the nation for cancer care in @USNews’“Best Hospitals” ranking. Read more: bit.ly/4lZOVwH #BestHospitals #EndCancer
10
61
9
202
27,937
👉👉👉Leukemia #DreamTeam after Thursday Leukemia Research meeting discussing future directions 🧭 in #leusm & #MPNSM research together 🔬 🥼 🩸 | #endcancer | @doctorpemm
1
1
17
911